Related Experiment Video
Updated: Jun 14, 2025

Sarcomere Shortening of Pluripotent Stem Cell-Derived Cardiomyocytes using Fluorescent-Tagged Sarcomere Proteins.
Published on: March 3, 2021
Desmoplakin loss leads to PKC-dependent insertion of series sarcomeres and contractile dysfunction in cardiomyocytes
Ilhan Gokhan1, Xia Li1, Jack M Sendek1
1Department of Biomedical Engineering, Yale University, New Haven, CT.
Insights
Desmoplakin (DSP) mutations cause heart failure by altering sarcomere length regulation. Protein kinase C inhibition may offer a therapeutic target for desmoplakin cardiomyopathy.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Biomechanical Engineering
Background:
- Desmoplakin (DSP) mutations are linked to high-penetrance cardiomyopathy.
- DSP mutations cause ventricular tachyarrhythmias, fibro-fatty infiltration, and dilated cardiomyopathy.
- The precise mechanism connecting DSP mutations to heart failure remains unclear.
Purpose of the Study:
- To model desmoplakin cardiomyopathy using induced pluripotent stem cell-derived engineered heart tissues (EHTs).
- To investigate the mechanobiology underlying desmoplakin haploinsufficiency.
- To identify novel therapeutic targets for desmoplakin cardiomyopathy.
Main Methods:
- Utilized iPSC-derived EHTs with DSP haploinsufficiency (R451G mutation).
- Assessed contractile function and sarcomere length in EHTs.
- Performed cell biology assays in 2D cardiomyocytes.
- Investigated the role of protein kinase C (PKC) and force transmission at the intercalated disc.
Main Results:
- DSP-mutant EHTs exhibited hypocontractility and ventricular dilation, recapitulating patient phenotypes.
- Shortened resting sarcomere length was observed in DSP-mutant tissues, dependent on PKC activity.
- Increased mechanical load on α-catenin suggested force redistribution to adherens junctions.
- PKC inhibition rescued the shortened sarcomere length phenotype.
Conclusions:
- Identified a novel mechanism of systolic dysfunction in desmoplakin cardiomyopathy involving sarcomere length regulation.
- Demonstrated altered force transmission at the intercalated disc as a key factor.
- Highlighted PKC as a potential therapeutic target for desmoplakin cardiomyopathy.
Background:
Mutations in DSP, which encodes the protein desmoplakin, lead to cardiomyopathy with unusually high penetrance. Clinical features include ventricular tachyarrhythmias, fibro-fatty infiltration of both ventricles, and ultimately dilated cardiomyopathy. While some data have been gathered to explain the electrophysiological and contractile consequences of desmoplakin cardiomyopathy, a comprehensive mechanism linking DSP mutations to ventricular dilation and heart failure remains elusive.
Methods:
We use iPSC-derived engineered heart tissue (EHT) bearing a functional desmoplakin haploinsufficiency to model the heart failure phenotype that occurs in desmoplakin cardiomyopathy. Functional haploinsufficiency is secondary to a missense mutation, R451G, that results in proteolytic degradation of desmoplakin with no detectable protein. We complement functional data obtained in tissue-engineered constructs with cell biology assays in 2D cardiomyocytes to glean insights into the mechanism and mechanobiology of desmoplakin cardiomyopathy.
Results:
Engineered heart tissues harboring a desmoplakin insufficiency recapitulate a patient phenotype notable for hypocontractility and ventricular dilation. Surprisingly, DSP-mutant tissues exhibited a shortened resting sarcomere length that was dependent on protein kinase C activity. Concurrently, mechanical load on α-catenin was increased, suggesting a mechanism by which desmosomal insufficiency redistributes force to adherens junctions. Excessive loading on adherens junctions may act as a stimulus for avid insertion of series sarcomeres, shortening the length per sarcomere, and resulting in a contractile deficit. PKC inhibition rescues shortened sarcomere length in DSP-mutant tissues, suggesting that it could be a target for future molecular therapies.
Conclusions:
Our study uncovers a novel mechanism underlying systolic dysfunction in desmoplakin cardiomyopathy. We not only recapitulate the disease phenotype, but we identify sarcomere length regulation through altered force transmission at the intercalated disc as a previously-unrecognized mechanism.
More Related Videos
11:00Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
Published on: September 18, 2017
10:56Analysis of Cardiomyocyte Development using Immunofluorescence in Embryonic Mouse Heart
Published on: March 26, 2015
Related Concept Videos
Desmosomes
Cytoskeletal Linker Proteins - Plakins
The Sarcomere
Each...
Satellite Stem Cells and Muscular Dystrophy
Structure of Cardiac Muscles
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
Cross-bridge Cycle